HomeARQT • NASDAQ
Arcutis Biotherapeutics Inc
Follow
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 81.50M | 164.13% |
Operating expense | 88.62M | 14.40% |
Net income | -15.89M | 69.64% |
Net profit margin | -19.49 | 88.51% |
Earnings per share | -0.13 | 69.05% |
EBITDA | -14.20M | 71.63% |
Effective tax rate | -2.20% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 190.82M | -47.35% |
Total assets | 352.43M | -20.76% |
Total liabilities | 213.46M | -17.37% |
Total equity | 138.97M | — |
Shares outstanding | 119.91M | — |
Price to book | 14.98 | — |
Return on assets | -10.49% | — |
Return on capital | -14.54% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -15.89M | 69.64% |
Cash from operations | 324.00K | 100.72% |
Cash from investing | 17.42M | 128.04% |
Cash from financing | 1.38M | -5.15% |
Net change in cash | 19.33M | 118.26% |
Free cash flow | -13.93M | 49.12% |
Previous close
$17.38
Day range
$17.29 - $18.07
Year range
$8.03 - $18.15
Market cap
2.11B USD
Avg Volume
1.64M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2016
Headquarters
Website
Employees
342
